509 related articles for article (PubMed ID: 21549782)
1. Improved formulation and lyophilization cycle for rBCG vaccine.
Jin TH; Nguyen L; Qu T; Tsao E
Vaccine; 2011 Jun; 29(29-30):4848-52. PubMed ID: 21549782
[TBL] [Abstract][Full Text] [Related]
2. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate.
Lueckel B; Bodmer D; Helk B; Leuenberger H
Pharm Dev Technol; 1998 Aug; 3(3):325-36. PubMed ID: 9742553
[TBL] [Abstract][Full Text] [Related]
3. Influence of processing conditions on the physical state of mannitol--implications in freeze-drying.
Liao X; Krishnamurthy R; Suryanarayanan R
Pharm Res; 2007 Feb; 24(2):370-6. PubMed ID: 17177113
[TBL] [Abstract][Full Text] [Related]
4. Crystallizing amino acids as bulking agents in freeze-drying.
Horn J; Tolardo E; Fissore D; Friess W
Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
[TBL] [Abstract][Full Text] [Related]
5. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of factors determining stability of BCG vaccine].
Janaszek W
Med Dosw Mikrobiol; 1992; 44(3-4):137-44. PubMed ID: 1305917
[TBL] [Abstract][Full Text] [Related]
7. Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers.
De Beer TR; Wiggenhorn M; Hawe A; Kasper JC; Almeida A; Quinten T; Friess W; Winter G; Vervaet C; Remon JP
Talanta; 2011 Feb; 83(5):1623-33. PubMed ID: 21238761
[TBL] [Abstract][Full Text] [Related]
8. Stabilisation of BCG vaccines.
Gheorghiu M; Lagranderie M; Balazuc AM
Dev Biol Stand; 1996; 87():251-61. PubMed ID: 8854025
[TBL] [Abstract][Full Text] [Related]
9. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying.
Tang XC; Pikal MJ
Pharm Res; 2005 Jul; 22(7):1176-85. PubMed ID: 16028019
[TBL] [Abstract][Full Text] [Related]
11. Development of Robust Freeze-Drying Process for Long-Term Stability of rVSV-SARS-CoV-2 Vaccine.
Khan MDFH; Youssef M; Nesdoly S; Kamen AA
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932234
[TBL] [Abstract][Full Text] [Related]
12. Effect of controlled ice nucleation on primary drying stage and protein recovery in vials cooled in a modified freeze-dryer.
Passot S; Tréléa IC; Marin M; Galan M; Morris GJ; Fonseca F
J Biomech Eng; 2009 Jul; 131(7):074511. PubMed ID: 19640147
[TBL] [Abstract][Full Text] [Related]
13. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage.
Lueckel B; Helk B; Bodmer D; Leuenberger H
Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554
[TBL] [Abstract][Full Text] [Related]
14. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
[TBL] [Abstract][Full Text] [Related]
15. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulations.
Hawe A; Friess W
Eur J Pharm Biopharm; 2006 Nov; 64(3):316-25. PubMed ID: 16875806
[TBL] [Abstract][Full Text] [Related]
16. Adverse effect of cake collapse on the functional integrity of freeze-dried bull spermatozoa.
Hara H; Tagiri M; Hwang IS; Takahashi M; Hirabayashi M; Hochi S
Cryobiology; 2014 Jun; 68(3):354-60. PubMed ID: 24747720
[TBL] [Abstract][Full Text] [Related]
17. Optimising the viability during storage of freeze-dried cell preparations of Campylobacter jejuni.
Portner DC; Leuschner RG; Murray BS
Cryobiology; 2007 Jun; 54(3):265-70. PubMed ID: 17482158
[TBL] [Abstract][Full Text] [Related]
18. Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate.
Lal M; Priddy S; Bourgeois L; Walker R; Pebley W; Brown J; Desai J; Darsley MJ; Kristensen D; Chen D
Vaccine; 2013 Oct; 31(42):4759-64. PubMed ID: 23965220
[TBL] [Abstract][Full Text] [Related]
19. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270
[TBL] [Abstract][Full Text] [Related]
20. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
